| Literature DB >> 8800080 |
Abstract
Many Canadians are interested in alternative medicine, and burgeoning public interest in herbal remedies has not gone unnoticed by Canada's drug companies. McNeil Consumer Products recently began selling a migraine prophylaxis made from the plant feverfew. Physicians who would like to see herbal medications subjected to outcome studies and quality-control standards, with evidence of risks and benefits being made available to consumers, welcome the interest the companies are showing. Meanwhile, physicians and pharmacists are trying to respond to consumer demand by increasing their own knowledge about herbal medications.Entities:
Mesh:
Year: 1996 PMID: 8800080 PMCID: PMC1487950
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262